- For the treatment of newly diagnosed adult patients with Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) in chronic phase
- For the treatment of chronic phase and accelerated phase Ph+ CML in adult patients resistant to or intolerant to prior therapy that included GleevecR
Coverage of drugs is first determined by the member’s pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document.